RIYADH — The Saudi Food and Drug Authority (SFDA) has approved the registration of ZENBEXUS (iberdomide) for the treatment of adult patients with relapsed or refractory multiple myeloma in combination ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results